health
Delhi High Court Flags Safety Issues in HPV Vaccine Rollout
Archived — last updated
The Delhi High Court has raised concerns over the safety of the HPV vaccine rollout in India, citing previous adverse events. The court is hearing a public interest litigation on the matter.
Latest updates
Delhi High Court Flags Safety Issues in HPV Vaccine Rollout
The Delhi High Court has expressed concerns over the safety of the HPV vaccine rollout in India. The court is hearing a public interest litigation (PIL) on the matter, which has raised questions about the Centre's decision to roll out the vaccine under the Universal Immunisation Programme. The PIL has cited previous serious adverse events from the vaccine, which has raised concerns among health experts. The court has directed the Centre to respond to the PIL, which is expected to lead to further discussions on the safety of the vaccine. The HPV vaccine is aimed at preventing cervical cancer, but the safety concerns have raised questions about its effectiveness.
Delhi High Court Hears Plea Against Rollout of HPV Vaccines Without Adequate Study
The Delhi High Court has taken up a plea against the rollout of Human Papillomavirus (HPV) vaccines without adequate study and research. The court has expressed concerns over the lack of scientific evidence supporting the vaccines' safety and efficacy. The plea, filed by a group of citizens, argues that the government's decision to introduce the vaccines without conducting thorough research is a violation of the principles of medical ethics. The court has directed the government to respond to the plea, which is expected to be heard in the coming weeks. The rollout of HPV vaccines has been a contentious issue in India, with some experts raising concerns over the potential risks and side effects of the vaccines. The government has maintained that the vaccines are safe and effective, but the court's intervention has sparked renewed debate over the issue.
Delhi High Court Hears Plea Against HPV Vaccines
The Delhi High Court has heard a plea against the rollout of HPV vaccines without adequate study. The petitioners have raised concerns about the safety and efficacy of the vaccines. The court has asked the government to respond to the petition within two weeks. The development has sparked a debate about the safety and efficacy of HPV vaccines, with some experts raising concerns about the lack of adequate study.
Delhi High Court Raises Concerns Over HPV Vaccine Rollout
The Delhi High Court has raised concerns over the rollout of HPV vaccines without adequate study and research. The court has sought a response from the government on the issue. The court's move comes after a petition was filed against the government's decision to introduce the vaccine without proper research. The government has been asked to provide details about the vaccine's safety and efficacy.
Very important issue: Delhi High Court on plea against rollout of HPV vaccines without adequate study
Very important issue: Delhi High Court on plea against rollout of HPV vaccines without adequate study Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.